The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 11, 2016

Interview with the President & CEO: Quality Systems, Inc. (NASDAQ:QSII)

Frantz, Rusty
Rusty Frantz was appointed President and Chief Executive Officer at Quality Systems, Inc. effective July 1, 2015 and was named a member of the company's board of directors in August 2015. Most recently, Mr. Frantz spent eight years serving in varying roles with increasing responsibility at CareFusion Corp., a San Diego-based global medical technology corporation serving the health care industry. From 2011 until March 2015, when CareFusion Corp. was acquired by Becton, Dickinson and Company — BD — Mr. Frantz served as Senior Vice President and General Manager of the global dispensing division. During this time, he spearheaded a transformational medication management strategy across three global brands — Pyxis, Rowa and CareFusion SmartWorks — which comprised $1 billion in global revenue. This was a key strategic driver in the acquisition of CareFusion Corp. by BD. Prior to heading the global dispensing division, Mr. Frantz was Vice President of Research and Development of the Pyxis business unit, where he led the process to bring the highly successful Pyxis ES medication dispensing solution to market. He also served as General Manager of Pyxis Perioperative Solutions, a leader in hospital and health system supply management solutions. Earlier, Mr. Frantz held the role of Chief Technology Officer and Co-Founder of OutPurchase, a provider of cloud-based procurement solutions and services. He began his career as one of the first employees at Omnicell, a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the health care continuum. Mr. Frantz holds a Bachelor of Science in engineering from the Maine Maritime Academy and a Master of Engineering from Stanford University. Profile
TWST: Last year, you started what you described as a “positive and transformative” journey for QSI. What does that involve, and where are we in the transformation?

Mr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy